These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 9275062

  • 1. Oncogene transformation of PC Cl3 clonal thyroid cell line induces an autonomous pattern of proliferation that correlates with a loss of basal and stimulated phosphotyrosine phosphatase activity.
    Florio T, Scorziello A, Thellung S, Salzano S, Berlingieri MT, Fusco A, Schettini G.
    Endocrinology; 1997 Sep; 138(9):3756-63. PubMed ID: 9275062
    [Abstract] [Full Text] [Related]

  • 2. The activation of the phosphotyrosine phosphatase eta (r-PTP eta) is responsible for the somatostatin inhibition of PC Cl3 thyroid cell proliferation.
    Florio T, Arena S, Thellung S, Iuliano R, Corsaro A, Massa A, Pattarozzi A, Bajetto A, Trapasso F, Fusco A, Schettini G.
    Mol Endocrinol; 2001 Oct; 15(10):1838-52. PubMed ID: 11579215
    [Abstract] [Full Text] [Related]

  • 3. Somatostatin inhibits PC Cl3 thyroid cell proliferation through the modulation of phosphotyrosine activity. Impairment of the somatostatinergic effects by stable expression of E1A viral oncogene.
    Florio T, Scorizello A, Fattore M, D'Alto V, Salzano S, Rossi G, Berlingieri MT, Fusco A, Schettini G.
    J Biol Chem; 1996 Mar 15; 271(11):6129-36. PubMed ID: 8626400
    [Abstract] [Full Text] [Related]

  • 4. [The activation of the phosphotyrosine phosphatase eta is responsible for the somatostatin inhibition of PCCl3 thyroid cell proliferation].
    Florio T, Arena S, Thellung S, Iuliano R, Corsaro A, Massa A, Villa V, Pattarozzi A, Diana F, Fusco A, Schettini G.
    Minerva Endocrinol; 2001 Dec 15; 26(4):277-83. PubMed ID: 11782716
    [Abstract] [Full Text] [Related]

  • 5. Inhibitory and stimulatory effects of somatostatin on two human pancreatic cancer cell lines: a primary role for tyrosine phosphatase SHP-1.
    Douziech N, Calvo E, Coulombe Z, Muradia G, Bastien J, Aubin RA, Lajas A, Morisset J.
    Endocrinology; 1999 Feb 15; 140(2):765-77. PubMed ID: 9927304
    [Abstract] [Full Text] [Related]

  • 6. Protein tyrosine kinase inhibitors block the stimulatory actions of phosphotyrosine phosphatase inhibitors to increase cell proliferation, alkaline phosphatase activity, and collagen synthesis in normal human bone cells.
    Yoon HK, Baylink DJ, Lau KH.
    Am J Nephrol; 2000 Feb 15; 20(2):153-62. PubMed ID: 10773618
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of mitogen-activated protein kinase activity and proliferation of an early osteoblast cell line (MBA 15.4) by dexamethasone: role of protein phosphatases.
    Hulley PA, Gordon F, Hough FS.
    Endocrinology; 1998 May 15; 139(5):2423-31. PubMed ID: 9564854
    [Abstract] [Full Text] [Related]

  • 8. Alpha 1 B, but not alpha 1A, adrenoreceptor activates calcium influx through the stimulation of a tyrosine kinase/phosphotyrosine phosphatase pathway, following noradrenaline-induced emptying of IP3 sensitive calcium stores, in PC Cl3 rat thyroid cell line.
    Meucci O, Scorziello A, Avallone A, Florio T, D'Alto V, Fattore M, Schettini G.
    Biochem Biophys Res Commun; 1995 Apr 17; 209(2):630-8. PubMed ID: 7537494
    [Abstract] [Full Text] [Related]

  • 9. Antiproliferative signaling of luteinizing hormone-releasing hormone in human endometrial and ovarian cancer cells through G protein alpha(I)-mediated activation of phosphotyrosine phosphatase.
    Gründker C, Völker P, Emons G.
    Endocrinology; 2001 Jun 17; 142(6):2369-80. PubMed ID: 11356684
    [Abstract] [Full Text] [Related]

  • 10. Phosphatase activity in the arterial wall after balloon injury: effect of somatostatin analog octreotide.
    Yamashita M, Dimayuga P, Kaul S, Shah PK, Regnstrom J, Nilsson J, Cercek B.
    Lab Invest; 1999 Aug 17; 79(8):935-44. PubMed ID: 10462031
    [Abstract] [Full Text] [Related]

  • 11. Effects of protein tyrosine phosphatase inhibitors on EGF- and insulin-dependent mammary epithelial cell growth.
    McIntyre BS, Briski KP, Hosick HL, Sylvester PW.
    Proc Soc Exp Biol Med; 1998 Feb 17; 217(2):180-7. PubMed ID: 9452142
    [Abstract] [Full Text] [Related]

  • 12. Association between the expression of E1A oncogene and increased sensitivity to growth inhibition induced by sustained levels of cAMP in rat thyroid cells.
    Villone G, De Vita G, Chieffi P, Picascia A, Stanzione R, Santoro M, Fusco A, Tramontano D.
    Eur J Endocrinol; 2000 Mar 17; 142(3):286-93. PubMed ID: 10700724
    [Abstract] [Full Text] [Related]

  • 13. The phosphotyrosine phosphatase eta mediates somatostatin inhibition of glioma proliferation via the dephosphorylation of ERK1/2.
    Massa A, Barbieri F, Aiello C, Iuliano R, Arena S, Pattarozzi A, Corsaro A, Villa V, Fusco A, Zona G, Spaziante R, Schettini G, Florio T.
    Ann N Y Acad Sci; 2004 Dec 17; 1030():264-74. PubMed ID: 15659806
    [Abstract] [Full Text] [Related]

  • 14. Rat protein tyrosine phosphatase eta suppresses the neoplastic phenotype of retrovirally transformed thyroid cells through the stabilization of p27(Kip1).
    Trapasso F, Iuliano R, Boccia A, Stella A, Visconti R, Bruni P, Baldassarre G, Santoro M, Viglietto G, Fusco A.
    Mol Cell Biol; 2000 Dec 17; 20(24):9236-46. PubMed ID: 11094075
    [Abstract] [Full Text] [Related]

  • 15. Autocrine regulation of human prostate carcinoma cell proliferation by somatostatin through the modulation of the SH2 domain containing protein tyrosine phosphatase (SHP)-1.
    Zapata PD, Ropero RM, Valencia AM, Buscail L, López JI, Martín-Orozco RM, Prieto JC, Angulo J, Susini C, López-Ruiz P, Colás B.
    J Clin Endocrinol Metab; 2002 Feb 17; 87(2):915-26. PubMed ID: 11836342
    [Abstract] [Full Text] [Related]

  • 16. The somatostatin receptor SSTR1 is coupled to phosphotyrosine phosphatase activity in CHO-K1 cells.
    Florio T, Rim C, Hershberger RE, Loda M, Stork PJ.
    Mol Endocrinol; 1994 Oct 17; 8(10):1289-97. PubMed ID: 7854346
    [Abstract] [Full Text] [Related]

  • 17. Thyroid cell transformation inhibits the expression of a novel rat protein tyrosine phosphatase.
    Zhang L, Martelli ML, Battaglia C, Trapasso F, Tramontano D, Viglietto G, Porcellini A, Santoro M, Fusco A.
    Exp Cell Res; 1997 Aug 25; 235(1):62-70. PubMed ID: 9281353
    [Abstract] [Full Text] [Related]

  • 18. erbB family receptor expression and growth regulation in a newly isolated human breast cancer cell line.
    Ethier SP, Kokeny KE, Ridings JW, Dilts CA.
    Cancer Res; 1996 Feb 15; 56(4):899-907. PubMed ID: 8631031
    [Abstract] [Full Text] [Related]

  • 19. Differential response of normal, dedifferentiated and transformed thyroid cell lines to cisplatin treatment.
    Muscella A, Urso L, Calabriso N, Ciccarese A, Migoni D, Fanizzi FP, Di Jeso B, Storelli C, Marsigliante S.
    Biochem Pharmacol; 2005 Dec 19; 71(1-2):50-60. PubMed ID: 16297374
    [Abstract] [Full Text] [Related]

  • 20. Protein tyrosine phosphatase-eta expression is upregulated by the PKA-dependent and is downregulated by the PKC-dependent pathways in thyroid cells.
    Martelli ML, Trapasso F, Bruni P, Berlingieri MT, Battaglia C, Vento MT, Belletti B, Iuliano R, Santoro M, Viglietto G, Fusco A.
    Exp Cell Res; 1998 Nov 25; 245(1):195-202. PubMed ID: 9828116
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.